EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered probiotic cocktail with two cascade metabolic Escherichia coli for the treatment of hyperlysinemia

Feng Geng, Mingyu Wu, Pan Yang, Xueling Li, Xiaohong Pan, Yadi Wang, Junhong Lü

Frontiers in Microbiology · 30.05.2024 · 15

DOI: 10.3389/fmicb.2024.1366017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 30.05.2024. Verfasst von Feng Geng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Binzhou Medical University, Yantai, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineering probiotics have emerged as a potential strategy for the treatment of metabolic diseases. However, due to the exceptional complexity of these metabolic disorders and the intricate relationship between gut microbes, it is difficult to achieve an ideal therapeutic effect in a specific metabolic disorder using only a single engineered strain. In this work, we proposed a probiotic cocktail strategy by engineering two cascade metabolic bacteria to treat hyperlysinemia, an inherited lysine metabolic disorder with loss of α-aminoadipate semialdehyde synthase (AASS) activity. A probiotic E. coli Nissle 1917 strain EcNT (pTLS) with a heterologous enzyme pathway in Saccharomyces cerevisiae was engineered to metabolize the excess lysine. Another one EcNT (pK25) was engineered to consume the products of lysine metabolism. The bacterial cocktail enables the maintenance of a metabolic cascade with AASS-like functional activity to maintain the blood lysine concentrations and downstream metabolites. In vitro experimental results showed that the cocktail bacteria had a better metabolic capacity and metabolites balance at a ratio of EcNT (pTLS) and EcNT (pK25) of 1:2. Feeding of the cocktail bacteria to the mouse model effectively reduced the concentration of lysine and balanced saccharopine in the plasma of hyperlysinemia-like mice. These findings not only provide a promising strategy of probiotic stains for the treatment of hyperlysinemia but also highlight the potential of engineered cascade cocktails to intervene and even cure other inherited metabolic diseases.

Schlagwörter

Stichwörter der Autor:innen

Escherichia colicocktailengineered probioticshyperlysinemiametabolic diseases

Autor:innen und Institutionen

  • College of Pharmacy, Binzhou Medical University, Yantai, China.
  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
  • College of Public Health, Shanghai University of Medicine & Health Sciences, Shanghai, China.

Zitieren

APA

Geng, F., Wu, M., Yang, P., Li, X., Pan, X., Wang, Y., & Lü, J. (2024). Engineered probiotic cocktail with two cascade metabolic Escherichia coli for the treatment of hyperlysinemia. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1366017

Vancouver

Geng F, Wu M, Yang P, Li X, Pan X, Wang Y, et al. Engineered probiotic cocktail with two cascade metabolic Escherichia coli for the treatment of hyperlysinemia. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1366017

BibTeX
@article{Geng2024,
  author = {Geng, Feng and Wu, Mingyu and Yang, Pan and Li, Xueling and Pan, Xiaohong and Wang, Yadi and Lü, Junhong},
  title = {Engineered probiotic cocktail with two cascade metabolic Escherichia coli for the treatment of hyperlysinemia},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1366017}
}
Kostenlos starten →